ID   NADK_ECOLI              Reviewed;         292 AA.
AC   P0A7B3; P37768; P46140; P77490;
DT   07-JUN-2005, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 1.
DT   15-MAR-2017, entry version 100.
DE   RecName: Full=NAD kinase {ECO:0000255|HAMAP-Rule:MF_00361};
DE            EC=2.7.1.23 {ECO:0000255|HAMAP-Rule:MF_00361};
DE   AltName: Full=ATP-dependent NAD kinase {ECO:0000255|HAMAP-Rule:MF_00361};
GN   Name=nadK {ECO:0000255|HAMAP-Rule:MF_00361}; Synonyms=yfjB, yfjE;
GN   OrderedLocusNames=b2615, JW2596;
OS   Escherichia coli (strain K12).
OC   Bacteria; Proteobacteria; Gammaproteobacteria; Enterobacterales;
OC   Enterobacteriaceae; Escherichia.
OX   NCBI_TaxID=83333;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=9205837; DOI=10.1093/dnares/4.2.91;
RA   Yamamoto Y., Aiba H., Baba T., Hayashi K., Inada T., Isono K.,
RA   Itoh T., Kimura S., Kitagawa M., Makino K., Miki T., Mitsuhashi N.,
RA   Mizobuchi K., Mori H., Nakade S., Nakamura Y., Nashimoto H.,
RA   Oshima T., Oyama S., Saito N., Sampei G., Satoh Y., Sivasundaram S.,
RA   Tagami H., Takahashi H., Takeda J., Takemoto K., Uehara K., Wada C.,
RA   Yamagata S., Horiuchi T.;
RT   "Construction of a contiguous 874-kb sequence of the Escherichia coli-
RT   K12 genome corresponding to 50.0-68.8 min on the linkage map and
RT   analysis of its sequence features.";
RL   DNA Res. 4:91-113(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=9278503; DOI=10.1126/science.277.5331.1453;
RA   Blattner F.R., Plunkett G. III, Bloch C.A., Perna N.T., Burland V.,
RA   Riley M., Collado-Vides J., Glasner J.D., Rode C.K., Mayhew G.F.,
RA   Gregor J., Davis N.W., Kirkpatrick H.A., Goeden M.A., Rose D.J.,
RA   Mau B., Shao Y.;
RT   "The complete genome sequence of Escherichia coli K-12.";
RL   Science 277:1453-1462(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=K12 / W3110 / ATCC 27325 / DSM 5911;
RX   PubMed=16738553; DOI=10.1038/msb4100049;
RA   Hayashi K., Morooka N., Yamamoto Y., Fujita K., Isono K., Choi S.,
RA   Ohtsubo E., Baba T., Wanner B.L., Mori H., Horiuchi T.;
RT   "Highly accurate genome sequences of Escherichia coli K-12 strains
RT   MG1655 and W3110.";
RL   Mol. Syst. Biol. 2:E1-E5(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-163.
RC   STRAIN=B178;
RX   PubMed=3045760; DOI=10.1093/nar/16.15.7545;
RA   Lipinska B., King J., Ang D., Georgopoulos C.;
RT   "Sequence analysis and transcriptional regulation of the Escherichia
RT   coli grpE gene, encoding a heat shock protein.";
RL   Nucleic Acids Res. 16:7545-7562(1988).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 194-292.
RC   STRAIN=K12;
RX   PubMed=3037486; DOI=10.1093/nar/15.13.5041;
RA   Rostas K., Morton S.J., Picksley S.M., Lloyd R.G.;
RT   "Nucleotide sequence and LexA regulation of the Escherichia coli recN
RT   gene.";
RL   Nucleic Acids Res. 15:5041-5049(1987).
RN   [6]
RP   PROTEIN SEQUENCE OF 1-10, FUNCTION, CATALYTIC ACTIVITY, SUBSTRATE
RP   SPECIFICITY, BIOPHYSICOCHEMICAL PROPERTIES, ENZYME REGULATION,
RP   COFACTOR, AND SUBUNIT.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=11488932; DOI=10.1046/j.1432-1327.2001.02358.x;
RA   Kawai S., Mori S., Mukai T., Hashimoto W., Murata K.;
RT   "Molecular characterization of Escherichia coli NAD kinase.";
RL   Eur. J. Biochem. 268:4359-4365(2001).
RN   [7]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, AND
RP   ENZYME REGULATION.
RC   STRAIN=K12 / MG1655 / ATCC 47076;
RX   PubMed=3025169; DOI=10.1128/jb.169.1.184-188.1987;
RA   Zerez C.R., Moul D.E., Gomez E.G., Lopez V.M., Andreoli A.J.;
RT   "Negative modulation of Escherichia coli NAD kinase by NADPH and
RT   NADH.";
RL   J. Bacteriol. 169:184-188(1987).
RN   [8]
RP   IDENTIFICATION.
RX   PubMed=7984428; DOI=10.1093/nar/22.22.4756;
RA   Borodovsky M., Rudd K.E., Koonin E.V.;
RT   "Intrinsic and extrinsic approaches for detecting genes in a bacterial
RT   genome.";
RL   Nucleic Acids Res. 22:4756-4767(1994).
RN   [9]
RP   FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF ARG-175,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND BINDING SPECIFICITY.
RX   PubMed=15855156; DOI=10.1074/jbc.M502518200;
RA   Mori S., Kawai S., Shi F., Mikami B., Murata K.;
RT   "Molecular conversion of NAD kinase to NADH kinase through single
RT   amino acid residue substitution.";
RL   J. Biol. Chem. 280:24104-24112(2005).
CC   -!- FUNCTION: Involved in the regulation of the intracellular balance
CC       of NAD and NADP, and is a key enzyme in the biosynthesis of NADP.
CC       Catalyzes specifically the phosphorylation on 2'-hydroxyl of the
CC       adenosine moiety of NAD to yield NADP. It can use ATP and other
CC       nucleoside triphosphates (UTP, CTP, GTP, dATP, TTP) as phosphoryl
CC       donors, while nucleoside mono- or diphosphates and poly(P) can
CC       not. {ECO:0000255|HAMAP-Rule:MF_00361,
CC       ECO:0000269|PubMed:11488932, ECO:0000269|PubMed:15855156,
CC       ECO:0000269|PubMed:3025169}.
CC   -!- CATALYTIC ACTIVITY: ATP + NAD(+) = ADP + NADP(+).
CC       {ECO:0000255|HAMAP-Rule:MF_00361, ECO:0000269|PubMed:11488932,
CC       ECO:0000269|PubMed:15855156, ECO:0000269|PubMed:3025169}.
CC   -!- COFACTOR:
CC       Name=a divalent metal cation; Xref=ChEBI:CHEBI:60240;
CC         Evidence={ECO:0000255|HAMAP-Rule:MF_00361,
CC         ECO:0000269|PubMed:11488932};
CC   -!- ENZYME REGULATION: Competitively and allosterically inhibited by
CC       NADH and NADPH at physiological concentrations, whereas inhibition
CC       by NADP is only slight. Inhibited by p-chloromercuribenzoate and
CC       HgCl(2). {ECO:0000269|PubMed:11488932,
CC       ECO:0000269|PubMed:3025169}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2 mM for NAD (at pH 7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:11488932, ECO:0000269|PubMed:15855156,
CC         ECO:0000269|PubMed:3025169};
CC         KM=2.5 mM for ATP (at pH 7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:11488932, ECO:0000269|PubMed:15855156,
CC         ECO:0000269|PubMed:3025169};
CC         KM=4.1 mM for magnesium (at pH 7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:11488932, ECO:0000269|PubMed:15855156,
CC         ECO:0000269|PubMed:3025169};
CC         Vmax=12.86 umol/min/mg enzyme (at pH 7 and 37 degrees Celsius)
CC         {ECO:0000269|PubMed:11488932, ECO:0000269|PubMed:15855156,
CC         ECO:0000269|PubMed:3025169};
CC         Note=Kcat is 55 sec(-1) for kinase activity with ATP. Kcat is
CC         125 sec(-1) for kinase activity with NAD.;
CC       pH dependence:
CC         Optimum pH is between 7.2 and 7.5. {ECO:0000269|PubMed:11488932,
CC         ECO:0000269|PubMed:15855156, ECO:0000269|PubMed:3025169};
CC       Temperature dependence:
CC         Optimum temperature is 60 degrees Celsius and half of the
CC         activity is lost on treatment at 65 degrees Celsius for 10
CC         minutes. {ECO:0000269|PubMed:11488932,
CC         ECO:0000269|PubMed:15855156, ECO:0000269|PubMed:3025169};
CC   -!- SUBUNIT: Homohexamer. {ECO:0000269|PubMed:11488932}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000255|HAMAP-Rule:MF_00361}.
CC   -!- SIMILARITY: Belongs to the NAD kinase family. {ECO:0000255|HAMAP-
CC       Rule:MF_00361}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=X07863; Type=Frameshift; Positions=Several; Evidence={ECO:0000305};
CC       Sequence=Y00357; Type=Frameshift; Positions=204, 215, 282; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U36840; AAA79785.1; -; Genomic_DNA.
DR   EMBL; U00096; AAC75664.1; -; Genomic_DNA.
DR   EMBL; AP009048; BAA16500.1; -; Genomic_DNA.
DR   EMBL; X07863; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Y00357; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   PIR; B65040; B65040.
DR   RefSeq; NP_417105.1; NC_000913.3.
DR   RefSeq; WP_001059169.1; NZ_LN832404.1.
DR   ProteinModelPortal; P0A7B3; -.
DR   SMR; P0A7B3; -.
DR   BioGrid; 4260607; 19.
DR   BioGrid; 851428; 4.
DR   DIP; DIP-48103N; -.
DR   IntAct; P0A7B3; 3.
DR   STRING; 511145.b2615; -.
DR   PaxDb; P0A7B3; -.
DR   PRIDE; P0A7B3; -.
DR   EnsemblBacteria; AAC75664; AAC75664; b2615.
DR   EnsemblBacteria; BAA16500; BAA16500; BAA16500.
DR   GeneID; 947092; -.
DR   KEGG; ecj:JW2596; -.
DR   KEGG; eco:b2615; -.
DR   PATRIC; 32120629; VBIEscCol129921_2713.
DR   EchoBASE; EB2109; -.
DR   EcoGene; EG12192; nadK.
DR   eggNOG; ENOG4105F91; Bacteria.
DR   eggNOG; COG0061; LUCA.
DR   HOGENOM; HOG000227221; -.
DR   InParanoid; P0A7B3; -.
DR   KO; K00858; -.
DR   OMA; KLHWHEY; -.
DR   PhylomeDB; P0A7B3; -.
DR   BioCyc; EcoCyc:MONOMER0-541; -.
DR   BioCyc; MetaCyc:MONOMER0-541; -.
DR   BRENDA; 2.7.1.23; 2026.
DR   PRO; PR:P0A7B3; -.
DR   Proteomes; UP000000318; Chromosome.
DR   Proteomes; UP000000625; Chromosome.
DR   GO; GO:0005829; C:cytosol; IDA:EcoCyc.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0051287; F:NAD binding; IDA:UniProtKB.
DR   GO; GO:0003951; F:NAD+ kinase activity; IDA:EcoCyc.
DR   GO; GO:0019674; P:NAD metabolic process; IEA:InterPro.
DR   GO; GO:0006741; P:NADP biosynthetic process; IDA:EcoCyc.
DR   Gene3D; 2.60.200.30; -; 1.
DR   Gene3D; 3.40.50.10330; -; 1.
DR   HAMAP; MF_00361; NAD_kinase; 1.
DR   InterPro; IPR017438; ATP-NAD_kinase_dom_1.
DR   InterPro; IPR017437; ATP-NAD_kinase_PpnK-typ_all-b.
DR   InterPro; IPR016064; NAD/diacylglycerol_kinase.
DR   InterPro; IPR002504; NADK.
DR   PANTHER; PTHR20275; PTHR20275; 1.
DR   Pfam; PF01513; NAD_kinase; 1.
DR   SUPFAM; SSF111331; SSF111331; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Kinase; NAD; NADP; Nucleotide-binding; Reference proteome;
KW   Transferase.
FT   CHAIN         1    292       NAD kinase.
FT                                /FTId=PRO_0000120616.
FT   NP_BIND      73     74       NAD. {ECO:0000255|HAMAP-Rule:MF_00361}.
FT   NP_BIND     147    148       NAD. {ECO:0000255|HAMAP-Rule:MF_00361}.
FT   NP_BIND     188    193       NAD. {ECO:0000255|HAMAP-Rule:MF_00361}.
FT   ACT_SITE     73     73       Proton acceptor. {ECO:0000255|HAMAP-
FT                                Rule:MF_00361}.
FT   BINDING     158    158       NAD. {ECO:0000255|HAMAP-Rule:MF_00361}.
FT   BINDING     175    175       NAD. {ECO:0000255|HAMAP-Rule:MF_00361}.
FT   BINDING     177    177       NAD. {ECO:0000255|HAMAP-Rule:MF_00361}.
FT   BINDING     185    185       NAD; via carbonyl oxygen.
FT                                {ECO:0000255|HAMAP-Rule:MF_00361}.
FT   BINDING     247    247       NAD. {ECO:0000255|HAMAP-Rule:MF_00361}.
FT   SITE        175    175       Responsible for conferring strict
FT                                specificity to NAD.
FT   MUTAGEN     175    175       R->E: Does not exhibit NADH kinase
FT                                activity in addition to NAD kinase
FT                                activity. {ECO:0000269|PubMed:15855156}.
FT   MUTAGEN     175    175       R->G: Exhibits NADH kinase activity in
FT                                addition to NAD kinase activity. Reduces
FT                                the Vmax of the NAD kinase activity.
FT                                {ECO:0000269|PubMed:15855156}.
FT   MUTAGEN     175    175       R->H: Exhibits NADH kinase activity in
FT                                addition to NAD kinase activity.
FT                                {ECO:0000269|PubMed:15855156}.
FT   MUTAGEN     175    175       R->I: Does not exhibit NADH kinase
FT                                activity in addition to NAD kinase
FT                                activity. {ECO:0000269|PubMed:15855156}.
FT   MUTAGEN     175    175       R->K: Does not exhibit NADH kinase
FT                                activity in addition to NAD kinase
FT                                activity. {ECO:0000269|PubMed:15855156}.
FT   MUTAGEN     175    175       R->Q: Exhibits NADH kinase activity in
FT                                addition to NAD kinase activity.
FT                                {ECO:0000269|PubMed:15855156}.
FT   MUTAGEN     175    175       R->T: Exhibits NADH kinase activity in
FT                                addition to NAD kinase activity.
FT                                {ECO:0000269|PubMed:15855156}.
SQ   SEQUENCE   292 AA;  32566 MW;  D1E631658408F2E1 CRC64;
     MNNHFKCIGI VGHPRHPTAL TTHEMLYRWL CTKGYEVIVE QQIAHELQLK NVKTGTLAEI
     GQLADLAVVV GGDGNMLGAA RTLARYDIKV IGINRGNLGF LTDLDPDNAQ QQLADVLEGH
     YISEKRFLLE AQVCQQDCQK RISTAINEVV LHPGKVAHMI EFEVYIDEIF AFSQRSDGLI
     ISTPTGSTAY SLSAGGPILT PSLDAITLVP MFPHTLSARP LVINSSSTIR LRFSHRRNDL
     EISCDSQIAL PIQEGEDVLI RRCDYHLNLI HPKDYSYFNT LSTKLGWSKK LF
//
